In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 medication for ...

Rising use of weight loss injections may be linked to more gallbladder surgeries. Experts urge caution, deeper research and ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

With GLP-1 drugs rising in popularity, how are businesses adapting to a new type of consumer?

We’ve all heard of Ozempic by now. It’s only licensed for use as a diabetes treatment in the UK and US, but it's widely used ‘off label’ to help people lose weight. So much so, in fact, that its name ...

Experts explain what ‘Ozempic neck’ is, why it happens after rapid weight loss and what treatment options are available ...

Wegovy pills are now available in the U.S., offering a prescription-based, convenient alternative for weight management ...

Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.

Last year, there was a 15% annual increase in the operations and surgeons want more research.

Drugmaker Eli Lilly and Co. says the $3.5 billion manufacturing facility in Fogelsville, just outside Allentown, will make injectable drugs and devices.

People with diabetes who also suffer from heart failure were at less risk of serious health issues, including hospitalisation and even death, when they took an Ozempic-like pill to manage their health ...